IL236466B - Medicament form for release of active ingredients - Google Patents

Medicament form for release of active ingredients

Info

Publication number
IL236466B
IL236466B IL236466A IL23646614A IL236466B IL 236466 B IL236466 B IL 236466B IL 236466 A IL236466 A IL 236466A IL 23646614 A IL23646614 A IL 23646614A IL 236466 B IL236466 B IL 236466B
Authority
IL
Israel
Prior art keywords
release
active ingredients
medicament form
medicament
ingredients
Prior art date
Application number
IL236466A
Other languages
Hebrew (he)
Other versions
IL236466A0 (en
Inventor
Gernot Francas
Karl-Heinz Przyklenk
Original Assignee
Hennig Arzneimittel Gmbh & Co
Gernot Francas
PRZYKLENK Karl Heinz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hennig Arzneimittel Gmbh & Co, Gernot Francas, PRZYKLENK Karl Heinz filed Critical Hennig Arzneimittel Gmbh & Co
Publication of IL236466A0 publication Critical patent/IL236466A0/en
Publication of IL236466B publication Critical patent/IL236466B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
IL236466A 2012-06-25 2014-12-25 Medicament form for release of active ingredients IL236466B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102012105528.9A DE102012105528A1 (en) 2012-06-25 2012-06-25 Pharmaceutical form for the release of active substances
PCT/EP2013/063162 WO2014001267A2 (en) 2012-06-25 2013-06-24 Medicament form for release of active ingredients

Publications (2)

Publication Number Publication Date
IL236466A0 IL236466A0 (en) 2015-02-26
IL236466B true IL236466B (en) 2019-02-28

Family

ID=48656002

Family Applications (1)

Application Number Title Priority Date Filing Date
IL236466A IL236466B (en) 2012-06-25 2014-12-25 Medicament form for release of active ingredients

Country Status (20)

Country Link
EP (2) EP2863896B1 (en)
AU (1) AU2013283473B2 (en)
BR (1) BR112014032578B1 (en)
CA (1) CA2877190C (en)
CO (1) CO7250447A2 (en)
DE (1) DE102012105528A1 (en)
DK (1) DK2679216T3 (en)
EA (1) EA030871B1 (en)
ES (2) ES2607447T3 (en)
HU (2) HUE025739T2 (en)
IL (1) IL236466B (en)
IN (1) IN2014MN02526A (en)
MX (1) MX367284B (en)
MY (1) MY168531A (en)
PH (1) PH12014502836B1 (en)
PL (2) PL2679216T3 (en)
PT (2) PT2863896T (en)
UA (1) UA118836C2 (en)
WO (1) WO2014001267A2 (en)
ZA (1) ZA201409506B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2936746C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
ES2862209T3 (en) 2017-07-20 2021-10-07 Intas Pharmaceuticals Ltd Solid non-pulsatile prolonged-release oral compositions containing betahistine
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
DE102018129419A1 (en) 2018-11-22 2020-05-28 Johannes Gutenberg-Universität Mainz Acrylate copolymer for pharmaceutical applications

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
IT1229237B (en) * 1989-05-08 1991-07-26 Prodotti Formenti SALTS OF (2- (PYRIDYL) ETHYL) METHYLAMINE
DE59308333D1 (en) * 1992-08-06 1998-05-07 Gergely Gerhard Easily consumable effervescent tablet
HRP970493A2 (en) 1996-09-23 1998-08-31 Wienman E. Phlips Oral delayed immediate release medical formulation and method for preparing the same
US6419960B1 (en) * 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
IT1309591B1 (en) 1999-03-05 2002-01-24 Formenti Farmaceutici Spa COMPOSITIONS WITH BETAISTINE CONTROLLED RELEASE.
DE10010509A1 (en) 2000-03-08 2001-09-13 Dresden Arzneimittel Oral pharmaceutical formulations with controllable release characteristics, e.g. rapid or delayed release, contain sucrose fatty acid ester as drug release controlling agent
DE10104880A1 (en) 2001-01-31 2002-08-08 Roehm Gmbh Multiparticulate pharmaceutical form, containing at least two differently coated pellet forms
DE60320965D1 (en) * 2003-07-04 2008-06-26 Formenti Farmaceutici Spa Betahistine preparations with controlled release
US20060280795A1 (en) * 2005-06-08 2006-12-14 Dexcel Pharma Technologies, Ltd. Specific time-delayed burst profile delivery system
EP2380564B1 (en) * 2007-04-04 2014-10-22 Sigmoid Pharma Limited An oral pharmaceutical composition
US20130323309A1 (en) * 2011-02-17 2013-12-05 Lupin Limited Sustained Release Composition of Memantine

Also Published As

Publication number Publication date
EA030871B1 (en) 2018-10-31
ES2546172T3 (en) 2015-09-21
HUE025739T2 (en) 2016-04-28
BR112014032578B1 (en) 2022-07-26
HUE031246T2 (en) 2017-06-28
DK2679216T3 (en) 2015-08-31
MX2014015660A (en) 2015-07-14
BR112014032578A2 (en) 2017-06-27
WO2014001267A2 (en) 2014-01-03
PT2863896T (en) 2016-12-21
EP2863896B1 (en) 2016-09-14
EP2679216B1 (en) 2015-05-27
CO7250447A2 (en) 2015-04-30
CA2877190A1 (en) 2014-01-03
PL2863896T3 (en) 2017-04-28
PH12014502836A1 (en) 2015-02-02
CA2877190C (en) 2020-01-07
AU2013283473A2 (en) 2015-01-22
MX367284B (en) 2019-08-13
DE102012105528A1 (en) 2014-01-02
EA201500044A1 (en) 2015-05-29
AU2013283473B2 (en) 2016-10-27
IL236466A0 (en) 2015-02-26
IN2014MN02526A (en) 2015-07-17
PH12014502836B1 (en) 2015-02-02
UA118836C2 (en) 2019-03-25
ZA201409506B (en) 2016-08-31
PL2679216T3 (en) 2015-12-31
EP2679216A1 (en) 2014-01-01
AU2013283473A1 (en) 2015-01-29
WO2014001267A3 (en) 2014-03-06
PT2679216E (en) 2015-10-09
EP2863896A2 (en) 2015-04-29
MY168531A (en) 2018-11-12
ES2607447T3 (en) 2017-03-31

Similar Documents

Publication Publication Date Title
IL238713A0 (en) Self-regulated release of active pharmaceutical ingredient
HK1212701A1 (en) Formulations of enzalutamide
HK1197027A1 (en) Use of estetrol as emergency contraceptive
IL236465B (en) Pharmaceutical form for extended release of active substances
HK1203149A1 (en) Novel dosage form and formulation of abediterol
HK1208188A1 (en) Formulations for the delivery of active ingredients
IL236466B (en) Medicament form for release of active ingredients
IL239670B (en) Monolithic dosage form for modified release of a combination of active ingredients
HUE047420T2 (en) Dosage form for the controlled release of active ingredients
EP2883546A4 (en) New differential-release pharmaceutical composition containing three active principles
TH1401007646A (en) Medicament form for release of active ingredients
AP2015008270A0 (en) Preparation for the treatment of tuberculosis
GB201104632D0 (en) Use of medicament

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed